Academic Radiology
Volume 17, Issue 11 , Pages 1394-1400 , November 2010

Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T

  • Alex Frydrychowicz, MD

      Affiliations

    • Department of Radiology, University of Wisconsin–Madison, 600 Highland Avenue, CSC E1/322, Madison, WI 53729
    • Department of Diagnostic Radiology, Medical Physics, University Hospital Freiburg, Freiburg, Germany
    • Corresponding Author InformationAddress correspondence to: A.F.
  • ,
  • Maximilian F. Russe

      Affiliations

    • Department of Diagnostic Radiology, Medical Physics, University Hospital Freiburg, Freiburg, Germany
  • ,
  • Jelena Bock, MSc

      Affiliations

    • Department of Diagnostic Radiology, Medical Physics, University Hospital Freiburg, Freiburg, Germany
  • ,
  • Aurélien F. Stalder, PhD

      Affiliations

    • Department of Diagnostic Radiology, Medical Physics, University Hospital Freiburg, Freiburg, Germany
    • Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China
  • ,
  • Thorsten A. Bley, MD

      Affiliations

    • Department of Radiology, University Hospital Hamburg, Hamburg, Germany
  • ,
  • Andreas Harloff, MD

      Affiliations

    • Department of Neurology and Clinical Neurophysiology, University Hospital Freiburg, Freiburg, Germany
  • ,
  • Michael Markl, PhD

      Affiliations

    • Department of Diagnostic Radiology, Medical Physics, University Hospital Freiburg, Freiburg, Germany

Received 26 March 2010 ,Accepted 26 May 2010.

References 

  1. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715–724
  2. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med. 1991;22:282–287
  3. Lauffer RB, Parmelee DJ, Ouellet HS, et al. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol. 1996;3(suppl):S356–S358
  4. Perreault P, Edelman MA, Baum RA, et al. MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology. 2003;229:811–820
  5. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography—multicenter comparative phase III study. Radiology. 2005;236:71–78
  6. Bluemke DA, Stillman AE, Bis KG, et al. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology. 2001;219:114–122
  7. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol. 2007;42:659–664
  8. Korosec FR, Frayne R, Grist TM, et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med. 1996;36:345–351
  9. Lim RP, Shapiro M, Wang EY, et al. 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol. 2008;29:1847–1854
  10. Willinek WA, Hadizadeh DR, von Falkenhausen M, et al. 4D time-resolved MR angiography with keyhole (4D-TRAK): more than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T. J Magn Reson Imaging. 2008;27:1455–1460
  11. Nielsen YW, Eiberg JP, Logager VB, et al. Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. Acad Radiol. 2009;16:654–661
  12. Naehle CP, Muller A, Willinek WA, et al. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. J Magn Reson Imaging. 2009;30:809–816
  13. Nissen JC, Attenberger UI, Fink C, et al. Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. Eur Radiol. 2009;19:1932–1938
  14. Maki JH, Wang M, Wilson GJ, et al. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging. 2009;30:1085–1092
  15. Iezzi R, Soulez G, Thurnher S, et al. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. Eur J Radiol. 2009;[Epub ahead of print]
  16. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202–1210
  17. Pruessmann KP. Parallel imaging at high field strength: synergies and joint potential. Top Magn Reson Imaging. 2004;15:237–244
  18. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med. 2005;54:748–754
  19. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging. 2006;1:128–137
  20. Cavagna FM, Marzola P, Dapra M, et al. Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol. 1994;29(suppl):S50–S53
  21. Stalder AF, Elverfeldt DV, Paul D, et al. Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Magn Reson Med. 2008;59:113–123

 Dr Markl receives funding from Deutsche Forschungsgemeinschaft (Bonn, Germany; grant MA 2383/4-1) and Bundesministerium für Bildung und Forschung (Bonn, Germany; grant 01EV0706).

PII: S1076-6332(10)00313-2

doi: 10.1016/j.acra.2010.05.022

Academic Radiology
Volume 17, Issue 11 , Pages 1394-1400 , November 2010